This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse

This study has been completed.
Information provided by:
Medtronic - MITG Identifier:
First received: September 12, 2005
Last updated: July 23, 2015
Last verified: July 2015
The primary objective of this study is to further evaluate the safety and effectiveness of the use of a sling device in women for stress and mixed urinary incontinence as well as vaginal vault prolapse.

Condition Intervention
Urinary Incontinence, Stress Mixed Incontinence Vaginal Vault Prolapse Device: Vaginal Sling

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: A Prospective Multicenter Clinical Study on a New Approach in Treating Stress and Mixed Incontinence and Vaginal Vault Prolapse

Resource links provided by NLM:

Further study details as provided by Medtronic - MITG:

Primary Outcome Measures:
  • Safety and efficacy for incontinence and prolapse procedures.

Secondary Outcome Measures:
  • Quality of Life Improvement as determined by Questionnaire.

Enrollment: 467
Study Start Date: March 2004
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Urinary incontinence is the involuntary loss of urine and can affect both men and women throughout their lives. Women are more likely to develop incontinence as a result of pregnancy and childbirth. There are approximately 11 million cases of incontinence in the US contributing to several different types of incontinence including :

  • Urge - 30% of the market
  • Stress - 30% of the market of which 85% are women
  • Combination urge and stress - 40%

Despite advances in behavioral therapy, pharmacological advances as well as development of minimally invasive surgical procedures, only one out of every twelve people affected actually seek help.


Globally, approximately 1 million women suffer uterovaginal prolapse annually and this condition can be associated with urinary incontinence. The breakdown of treatments for uterovaginal prolapse includes:

  • 20% - no treatment
  • 20% - non surgical management (pessary)
  • 60% - receive a surgical procedure of a suture repair or mesh repair

There were greater than 600,000 surgeries performed globally to treat prolapse. These numbers are projected to increase due to rapid, easy, and less costly methods as well as new products that facilitate the easier procedures.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Subject must be female and >18 years of age.
  • Subject must have genuine stress or mixed incontinence AND/OR evidence of pelvic organ prolapse.

Exclusion Criteria:

  • Any subject with clotting defects, bleeding disorders or receiving anticoagulant treatments AND is determined to be at risk for minimally invasive surgery as determined by the investigator
  • Subjects who currently have an untreated urinary tract infection
  • Subject is unable to comply with the study requirements, follow-up schedule, or to give valid informed consent.
  • Subject is pregnant or desires future pregnancies.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00223106

United States, Connecticut
US Surgical
Norwalk, Connecticut, United States, 06856
Sponsors and Collaborators
Medtronic - MITG
Study Director: Noreen A. Gannon Medtronic - MITG
  More Information Identifier: NCT00223106     History of Changes
Other Study ID Numbers: WHC03001
Study First Received: September 12, 2005
Last Updated: July 23, 2015

Keywords provided by Medtronic - MITG:
urge incontinence
urinary incontinence
vault prolapse
stess incontinence
mixed incontinence
urine leakage

Additional relevant MeSH terms:
Urinary Incontinence
Urinary Incontinence, Stress
Pelvic Organ Prolapse
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders
Pathological Conditions, Anatomical processed this record on August 18, 2017